{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:44:55Z","timestamp":1793054695104,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Beijing Municipal Science and Technology Commission","award":["Z191100006619106"],"award-info":[{"award-number":["Z191100006619106"]}]},{"name":"The CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-1-001"],"award-info":[{"award-number":["2023-I2M-1-001"]}]},{"name":"The National High Level Hospital Clinical Research Funding","award":["2022-GSP-GG-17"],"award-info":[{"award-number":["2022-GSP-GG-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin resistance is a pivotal risk factor for cardiovascular diseases, and the triglyceride-glucose (TyG) index is a well-established surrogate of insulin resistance. This study aimed to investigate the prognostic value of the TyG index and its ability in therapy guidance in patients with three-vessel disease (TVD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 8862 patients with TVD with available baseline TyG index data were included in the study. The endpoint was major adverse cardiac events (MACE). All patients received coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or medical therapy (MT) alone reasonably.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>An elevated TyG index was defined as the TyG index greater than 9.51. During a median follow-up of 7.5\u00a0years, an elevated TyG index was significantly associated with an increased risk of MACE (adjusted hazard ratio 1.161, 95% confidence interval 1.026\u20131.314, p\u2009=\u20090.018). The elevated TyG index was shown to have a more pronounced predictive value for MACE in patients with diabetes, but failed to predict MACE among those without diabetes, whether they presented with stable angina pectoris (SAP) or acute coronary syndrome (ACS). Meanwhile, the association between an elevated TyG index and MACE was also found in patients with left main involvement. Notably, CABG conferred a significant survival advantage over PCI in patients with a normal TyG index, but was not observed to be superior to PCI in patients with an elevated TyG index unless the patients had both ACS and diabetes. In addition, the benefit was shown to be similar between MT and revascularisation among patients with SAP and an elevated TyG index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TyG index is a potential indicator for risk stratification and therapeutic decision-making in patients with TVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-02063-4","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T10:03:04Z","timestamp":1701856984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutai","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"8","key":"2063_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation. 2023;147(8):e93\u2013621.","journal-title":"Circulation"},{"issue":"10","key":"2063_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1001\/jamainternmed.2014.3904","volume":"174","author":"SM Bradley","year":"2014","unstructured":"Bradley SM, Spertus JA, Kennedy KF, Nallamothu BK, Chan PS, Patel MR, Bryson CL, Malenka DJ, Rumsfeld JS. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174(10):1630\u20139.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2063_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"JK Min","year":"2011","unstructured":"Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58(8):849\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2063_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395.","journal-title":"Diabetes"},{"key":"2063_CR5","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metab Clin Exp. 2021;119:154766.","journal-title":"Metab Clin Exp"},{"issue":"7","key":"2063_CR6","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53(7):1270\u201387.","journal-title":"Diabetologia"},{"issue":"3","key":"2063_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jch.14155","volume":"23","author":"HV Minh","year":"2021","unstructured":"Minh HV, Tien HA, Sinh CT, Thang DC, Chen CH, Tay JC, Siddique S, Wang TD, Sogunuru GP, Chia YC, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich). 2021;23(3):529\u201337.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"2063_CR8","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2063_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090430","volume":"9","author":"SH Lee","year":"2014","unstructured":"Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, Lee JH, Yim HW, Kang MI, Lee WC, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS ONE. 2014;9(2): e90430.","journal-title":"PLoS ONE"},{"issue":"7","key":"2063_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/07853890.2018.1523549","volume":"50","author":"JL Jin","year":"2018","unstructured":"Jin JL, Sun D, Cao YX, Guo YL, Wu NQ, Zhu CG, Gao Y, Dong QT, Zhang HW, Liu G, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann Med. 2018;50(7):576\u201386.","journal-title":"Ann Med"},{"issue":"11","key":"2063_CR11","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.21037\/jtd.2018.10.79","volume":"10","author":"JL Jin","year":"2018","unstructured":"Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, Zhu CG, Gao Y, Dong QT, Zhang HW, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10(11):6137\u201346.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2063_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-020-01054-z","volume":"19","author":"L Wang","year":"2020","unstructured":"Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2063_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-019-0957-3","volume":"18","author":"E Luo","year":"2019","unstructured":"Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.","journal-title":"Cardiovasc Diabetol"},{"key":"2063_CR14","doi-asserted-by":"publisher","first-page":"6891537","DOI":"10.1155\/2019\/6891537","volume":"2019","author":"Q Mao","year":"2019","unstructured":"Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome. Dis Markers. 2019;2019:6891537.","journal-title":"Dis Markers"},{"issue":"1","key":"2063_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-021-01443-y","volume":"21","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Su Y, Shen J, Hou X, Li Y, Wang J, Liu B, Qiu D, Sun Z, Chen Y, et al. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022;21(1):3.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2063_CR16","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1016\/j.numecd.2021.07.027","volume":"31","author":"S Gao","year":"2021","unstructured":"Gao S, Ma W, Huang S, Lin X, Yu M. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutr Metab Cardiovasc Dis. 2021;31(11):3184\u201392.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2063_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-022-01606-5","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2063_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","volume":"13","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany MM, Mart\u00ednez-Rodr\u00edguez J, Gonz\u00e1lez-Luc\u00e1n M, Fern\u00e1ndez-Fern\u00e1ndez C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449\u201355.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"2063_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385.","journal-title":"Cell Metab"},{"issue":"1","key":"2063_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12944-020-1187-0","volume":"19","author":"GM Park","year":"2020","unstructured":"Park GM, Cho YR, Won KB, Yang YJ, Park S, Ann SH, Kim YG, Park EJ, Kim SJ, Lee SG, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):7.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2063_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, Ma J, Zhao Y, Zhu W, Wang J. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2063_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"key":"2063_CR23","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2063_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.33963\/KP.a2021.0104","volume":"79","author":"D Drwi\u0142a","year":"2021","unstructured":"Drwi\u0142a D, Rostoff P, Gajos G, Nessler J, Konduracka E. Prognostic value of the triglyceride-glucose index among non-diabetic patients with acute myocardial infarction at one-year follow-up. Kardiol Pol. 2021;79(10):1116\u201323.","journal-title":"Kardiol Pol"},{"issue":"3","key":"2063_CR25","first-page":"e4","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4\u201317.","journal-title":"Circulation"},{"issue":"19","key":"2063_CR26","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","volume":"141","author":"SV Arnold","year":"2020","unstructured":"Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American heart association. Circulation. 2020;141(19):e779\u2013806.","journal-title":"Circulation"},{"key":"2063_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/DMSO.S343374","volume":"15","author":"L Chen","year":"2022","unstructured":"Chen L, Ding XH, Fan KJ, Gao MX, Yu WY, Liu HL, Yu Y. Association between triglyceride-glucose index and 2-year adverse cardiovascular and cerebrovascular events in patients with type 2 diabetes mellitus who underwent off-pump coronary artery bypass grafting. Diabetes Metab Syndr Obes. 2022;15:439\u201350.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"18","key":"2063_CR28","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.117.027597","volume":"136","author":"M Gaudino","year":"2017","unstructured":"Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, Di Giammarco G, Fremes S, Glineur D, Grau J, He GW, et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation. 2017;136(18):1749\u201364.","journal-title":"Circulation"},{"issue":"3","key":"2063_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ejcts.2005.05.025","volume":"28","author":"RE Anderson","year":"2005","unstructured":"Anderson RE, Brismar K, Barr G, Ivert T. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Eur J Cardio-thoracic Surg. 2005;28(3):425\u201330.","journal-title":"Eur J Cardio-thoracic Surg"},{"issue":"4","key":"2063_CR30","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jtcvs.2005.05.049","volume":"130","author":"T Doenst","year":"2005","unstructured":"Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130(4):1144.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"2063_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11886-022-01646-z","volume":"24","author":"TL Scudeler","year":"2022","unstructured":"Scudeler TL, Godoy LC, Hoxha T, Kung A, Moreno PR, Farkouh ME. Revascularization strategies in patients with diabetes and acute coronary syndromes. Curr Cardiol Rep. 2022;24(3):201\u20138.","journal-title":"Curr Cardiol Rep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02063-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02063-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02063-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T10:06:08Z","timestamp":1701857168000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02063-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02063-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"2 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Fuwai Hospital and performed in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declares that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}